Suppr超能文献

雄激素受体基因在前列腺癌中的表达被雄激素受体直接抑制,通过募集赖氨酸特异性去甲基化酶 1。

Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1.

机构信息

Hematology-Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.

出版信息

Cancer Cell. 2011 Oct 18;20(4):457-71. doi: 10.1016/j.ccr.2011.09.001.

Abstract

Androgen receptor (AR) is reactivated in castration-resistant prostate cancer (CRPC) through mechanisms including marked increases in AR gene expression. We identify an enhancer in the AR second intron contributing to increased AR expression at low androgen levels in CRPC. Moreover, at increased androgen levels, the AR binds this site and represses AR gene expression through recruitment of lysine-specific demethylase 1 (LSD1) and H3K4me1,2 demethylation. AR similarly represses expression of multiple genes mediating androgen synthesis, DNA synthesis, and proliferation while stimulating genes mediating lipid and protein biosynthesis. Androgen levels in CRPC appear adequate to stimulate AR activity on enhancer elements, but not suppressor elements, resulting in increased expression of AR and AR repressed genes that contribute to cellular proliferation.

摘要

雄激素受体(AR)在去势抵抗性前列腺癌(CRPC)中通过包括 AR 基因表达显著增加的机制被重新激活。我们确定了 AR 第二内含子中的一个增强子,该增强子有助于在 CRPC 中低雄激素水平下增加 AR 的表达。此外,在雄激素水平升高的情况下,AR 结合该位点,并通过募集赖氨酸特异性去甲基化酶 1(LSD1)和 H3K4me1、2 去甲基化来抑制 AR 基因表达。AR 同样抑制介导雄激素合成、DNA 合成和增殖的多个基因的表达,同时刺激介导脂质和蛋白质生物合成的基因。CRPC 中的雄激素水平似乎足以刺激增强子元件上的 AR 活性,但不能抑制抑制子元件上的 AR 活性,从而导致 AR 表达增加和 AR 抑制基因表达增加,这有助于细胞增殖。

相似文献

引用本文的文献

6
Advancing therapeutics in small-cell lung cancer.小细胞肺癌治疗方法的进展
Nat Cancer. 2025 Jun 16. doi: 10.1038/s43018-025-00996-1.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验